Literature DB >> 16105535

Surgical outcome of patients with hepatocellular carcinoma originating in the caudate lobe.

Shinji Tanaka1, Mitsuo Shimada, Ken Shirabe, Shin-Ichiro Maehara, Eiji Tsujita, Akinobu Taketomi, Yoshihiko Maehara.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) originating in the caudate lobe is rare, and the treatment for this type of carcinoma is difficult because of its unique anatomic location.
METHODS: This retrospective study assessed the surgical outcome of patients with caudate lobe HCC. There were 20 cases of HCC originating in the caudate lobe among 435 patients with primary HCC who underwent hepatic resection in our department from 1990 to 2002. The caudate tumors were located in the Spiegel lobe in 3 patients, the paracaval portion in 15 patients, and the caudate process in 2 patients. Surgical procedures consisted of limited resection of the caudate lobe in 6 patients and extended caudate lobectomy in 14 patients. Recurrence was recognized in 12 patients, including 8 patients with multiple intrahepatic recurrences, 1 with peritoneal dissemination, and 1 with lymph node metastasis.
RESULTS: There was no significant difference in postoperative survival rate between patients who underwent limited resection of the caudate lobe and those who underwent extended caudate lobectomy. Compared with 415 patients with HCC originating in other locations, the 20 patients with caudate lobe HCC showed significantly more intraoperative blood loss (P<.05), longer operation time (P<.0001), and more postoperative complications (P<.005). Intrahepatic recurrence was more frequent in the caudate lobe HCC compared with HCC originating in other locations (40% vs 17.6%; P<.05). There was a significantly poor survival rate in the postoperative patients with caudate HCC (25.9% vs 54.1% for five-year survival; P=.01). Intrahepatic multiple recurrences were frequently recognized in the patients with caudate lobe HCC, indicating no significance for extended caudate lobectomy.
CONCLUSIONS: Because of the relatively poor prognosis in patients with caudate lobe HCC, adjuvant therapy combined with surgical operation should be considered.

Entities:  

Mesh:

Year:  2005        PMID: 16105535     DOI: 10.1016/j.amjsurg.2004.12.005

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  15 in total

Review 1.  Hepatocellular carcinoma in the caudate lobe of the liver: variations of its feeding branches on arteriography.

Authors:  Shiro Miyayama; Masashi Yamashiro; Yuichi Yoshie; Yoshiko Nakashima; Hiroshi Ikeno; Nobuaki Orito; Miki Yoshida; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2010-10-24       Impact factor: 2.374

2.  High dorsal resection for hepatocellular carcinoma: surgical plane and outcomes.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Masaru Aoki; Nao Yoshida; Tokio Higaki
Journal:  Quant Imaging Med Surg       Date:  2021-08

3.  Prognoses and Clinicopathological Characteristics for Hepatocellular Carcinoma Originating from the Caudate Lobe After Surgery.

Authors:  Shingo Shimada; Toshiya Kamiyama; Hideki Yokoo; Tatsuya Orimo; Akihisa Nagatsu; Takanori Ohata; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

4.  Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma.

Authors:  Peng Liu; Jia-Mei Yang; Wen-Yang Niu; Tong Kan; Feng Xie; Dian-Qi Li; Ye Wang; Yan-Ming Zhou
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

5.  Caudate lobe resection: an Egyptian center experience.

Authors:  Mohamed Abdel Wahab; Abdul Razzak Oluwagbemiga Lawal; Ehab EL Hanafy; Tarek Salah; Emad Hamdy; Ahmad M Sultan
Journal:  Langenbecks Arch Surg       Date:  2009-11       Impact factor: 3.445

6.  Precautions in caudate lobe resection: report of 11 cases.

Authors:  Zeng-Qing Wen; Yi-Qun Yan; Jia-Mei Yang; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

7.  Caudate Lobe Hepatocellular Carcinoma Treated with Sequential Transarterial Chemoembolization and Iodine 125 Seeds Implantation: A Single-Center Retrospective Study.

Authors:  Liangliang Yan; Lei Chen; Kun Qian; Xuefeng Kan; Hongsen Zhang; Bin Liang; Chuansheng Zheng
Journal:  Cancer Manag Res       Date:  2021-05-13       Impact factor: 3.989

8.  Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.

Authors:  Takashi Iizumi; Toshiyuki Okumura; Yuta Sekino; Hiroaki Takahashi; Yu-Lun Tsai; Daichi Takizawa; Toshiki Ishida; Yuichi Hiroshima; Masatoshi Nakamura; Shosei Shimizu; Takashi Saito; Haruko Numajiri; Masashi Mizumoto; Kei Nakai; Hideyuki Sakurai
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

9.  A case of hepatocellular carcinoma in the caudate lobe successfully treated by transcatheter arterial chemoembolization using drug-eluting beads.

Authors:  Dong Hoo Joh; Jin Dong Kim; Young Nam Kim; Ha Hun Song; Hyun Kim; Kyung Ho Song; Sang Jin Lee; Jeong Rok Lee; Won Joong Jeon; Byung Hyo Cha
Journal:  Korean J Hepatol       Date:  2010-12

10.  CT-Guided Percutaneous Step-by-Step Radiofrequency Ablation for the Treatment of Carcinoma in the Caudate Lobe.

Authors:  Jun Dong; Wang Li; Qi Zeng; Sheng Li; Xiao Gong; Lujun Shen; Siyue Mao; Annan Dong; Peihong Wu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.